Normal view MARC view ISBD view

Experiences of community-dwelling older adults living with multiple chronic conditions: a qualitative study. [electronic resource]

By:

Ploeg, Jenny

Contributor(s):

Producer: 20200403Description: e023345 p. digitalISSN:

2044-6055

Subject(s):

Online resources:

Available from publisher's website

In: BMJ open vol. 9

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

1541 Nutrition and infant lung functions: report of a National Heart, Lung and Blood Institute symposium.
1542 Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
by Ip, Emilia
1543 Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
by Nocito, Antonio
1544 Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction.
by Jun, Dae Won
1545 Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models.
by Coulon, Stephanie
1546 Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.
by Zhang, Yu-Kun Jennifer
1547 Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.
by Tamaki, Yosui
1548 Time-dependent changes in lipid metabolism in mice with methionine choline deficiency-induced fatty liver disease.
by Park, Han-Sol
1549 Methyl deficient diet aggravates experimental colitis in rats.
by Chen, Min
1550 Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
by Kaji, Kosuke
1551 Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
by Kitamura, Kumi
1552 Carbon monoxide protects against hepatic steatosis in mice by inducing sestrin-2 via the PERK-eIF2α-ATF4 pathway.
by Kim, Hyo Jeong
1553 p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice.
by Tomita, Kengo
1554 Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.
by Marcolin, Eder
1555 Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
by Sugino, Haruko
1556 Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
by Farrell, Geoffrey C